180 related articles for article (PubMed ID: 30254456)
1. The downregulated long noncoding RNA
Wang C; Wang G; Zhang Z; Wang Z; Ren M; Wang X; Li H; Yu Y; Liu J; Cai L; Li Y; Zhang D; Zhang C
Onco Targets Ther; 2018; 11():5631-5646. PubMed ID: 30254456
[TBL] [Abstract][Full Text] [Related]
2. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1.
Yang W; Zhang K; Li L; Xu Y; Ma K; Xie H; Zhou J; Cai L; Gong Y; Gong K
J Exp Clin Cancer Res; 2021 Mar; 40(1):92. PubMed ID: 33691743
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
[TBL] [Abstract][Full Text] [Related]
5. LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis.
Zhou Y; Li K; Zou X; Hua Z; Wang H; Bian W; Wang H; Chen F; Dai T
Bioengineered; 2021 Dec; 12(2):10862-10877. PubMed ID: 34666613
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of long noncoding RNA PGM5-AS1 correlates with tumor progression and predicts poor prognosis in clear cell renal cell carcinoma.
Qian M; Zheng JL; Kang N; Su YL
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10685-10690. PubMed ID: 31858536
[TBL] [Abstract][Full Text] [Related]
7. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
8. DHRS4-AS1 regulate gastric cancer apoptosis and cell proliferation by destabilizing DHX9 and inhibited the association between DHX9 and ILF3.
Xiao L; Zhang Y; Luo Q; Guo C; Chen Z; Lai C
Cancer Cell Int; 2023 Dec; 23(1):304. PubMed ID: 38041141
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the lncRNA ASB16-AS1 Decreases LARP1 Expression and Promotes Clear Cell Renal Cell Carcinoma Progression
Li M; Yin B; Chen M; Peng J; Mu X; Deng Z; Xiao J; Li W; Fan J
Front Oncol; 2020; 10():617105. PubMed ID: 33680937
[TBL] [Abstract][Full Text] [Related]
10. A regulatory circuit of lncRNA NLGN1-AS1 and Wnt signalling controls clear cell renal cell carcinoma phenotypes through FZD4-modulated pathways.
Gao H; Chen W; Pan G; Liu H; Qian J; Tang W; Wang W; Qian S
Aging (Albany NY); 2022 Sep; 15(24):15624-15639. PubMed ID: 36170021
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.
Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B
Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA DHRS4 antisense RNA 1 inhibits ectopic endometrial cell proliferation, migration, and invasion in endometriosis by regulating microRNA-139-5p expression.
Cui X; Zhou S; Lin Y
Bioengineered; 2022 Apr; 13(4):9792-9804. PubMed ID: 35414313
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of VHL protein expression promotes the progression of clear cell renal cell carcinoma.
Yang W; Zhou J; Zhang Z; Zhang K; Xu Y; Li L; Cai L; Gong Y; Gong K
Int J Biol Sci; 2022; 18(6):2583-2596. PubMed ID: 35414787
[No Abstract] [Full Text] [Related]
14. LncRNA DNAJC3-AS1 functions as oncogene in renal cell carcinoma via regulation of the miR-27a-3p/PRDM14 axis.
Na XY; Hu XQ; Zhao Y; Hu CH; Shang XS
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1291-1301. PubMed ID: 33629299
[TBL] [Abstract][Full Text] [Related]
15. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.
Zhou Y; Zhang Z; Wo M; Xu W
Bioengineered; 2021 Dec; 12(1):8994-9005. PubMed ID: 34643163
[TBL] [Abstract][Full Text] [Related]
16. AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease.
Nakken S; Eikrem Ø; Marti HP; Beisland C; Bostad L; Scherer A; Flatberg A; Beisvag V; Skandalou E; Furriol J; Strauss P
Cancer Cell Int; 2021 Dec; 21(1):690. PubMed ID: 34930263
[TBL] [Abstract][Full Text] [Related]
17. Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma.
Mu Z; Dong D; Wei N; Sun M; Wang W; Shao Y; Gao J; Yin P; Zhao C
Oncol Res; 2019 Jun; 27(6):653-661. PubMed ID: 30832752
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma.
Yang W; Zhou J; Zhang K; Li L; Xu Y; Ma K; Xie H; Cai L; Gong Y; Gong K
J Cancer; 2021; 12(9):2702-2714. PubMed ID: 33854630
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
20. LncRNA DHRS4-AS1 Inhibits the Stemness of NSCLC Cells by Sponging miR-224-3p and Upregulating TP53 and TET1.
Yan F; Zhao W; Xu X; Li C; Li X; Liu S; Shi L; Wu Y
Front Cell Dev Biol; 2020; 8():585251. PubMed ID: 33425890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
